glp-1 receptor agonist market top selling drugs us Valued at USD 62.86 Billion in 2025, Set to Grow at 17.5% CAGR Through 2034 GLP-1 Receptor Agonist Market Forecast

Especially for older adults who have the most to gain from a drug that lowers the risk of heart disease but also need to preserve muscle strength combining a muscle-preserving drug with GLP-1 agonists could be a big deal

But I think that as exenatide and other GLP-1 agonists are used over time, well get an increasing sense of their safety

In some people, weight loss can lead to looser or sagging skin

See FormBlends options or compare providers

doi: 10.1111/jdv.12629

Heres the catch: experts warn that most of these patches are made from herbal blends or supplements, and theres little to no clinical evidence showing they actually work